Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P58317 (
ZNF121
)
3
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MYC is a potent oncoprotein that modulates multiple cellular processes including proliferation, apoptosis, differentiation, stemness, senescence, and migration. Functioning primarily as a transcriptional factor, MYC interacts with a large number of proteins, and identification and characterization of MYC-interacting proteins are important for understanding how MYC functions. In this study, we used different systems to demonstrate that a novel zinc finger transcription factor,
ZNF121
, physically interacted with MYC, and the interaction involved their N-terminal regions. Overexpression of
ZNF121
increased, while its knockdown decreased, the expression of MYC in multiple epithelial cell lines, and MYC had similar effects on
ZNF121
expression. An expression correlation was also detectable in a panel of epithelial cell lines and a cohort of human
breast cancer
tissues. Functionally, knockdown of
ZNF121
in several breast epithelial cell lines attenuated the expressions of MYC and its target genes (e.g., EGR1, CDC2, and nucleolin) and slowed cell proliferation, accompanied by cell cycle arrest in the G1 phase and expression alteration of cell cycle regulators (cyclin D1, p14 and p21). Analysis of publically available databases showed that
ZNF121
expression is up-regulated in human
breast cancer
, and the up-regulation significantly associates with worse patient survival in the luminal A subtype of
breast cancer
. These findings establish
ZNF121
as a MYC-interacting protein with functional effects on MYC and cell proliferation.
...
PMID:Zinc finger factor ZNF121 is a MYC-interacting protein functionally affecting MYC and cell proliferation in epithelial cells. 2798